264
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

New RP‐HPLC Method with UV‐Detection for the Determination of Carvedilol in Human Serum

, &
Pages 1677-1685 | Received 08 Nov 2006, Accepted 12 Dec 2006, Published online: 17 Apr 2007
 

Abstract

Carvedilol has been used as an antihypertensive drug and also possesses antioxidant and antiproliferative effects. A simple and sensitive analytical method for carvedilol in human serum by using high performance liquid chromatography (HPLC) was developed. The method employs a liquid‐liquid extraction for isolation and sample concentration followed by reversed phase liquid chromatography (RPLC) analysis using ultraviolet (UV) detection at 238 nm. Analytes were extracted from serum samples, that were previously mixed with 300 µL of 0.1 N sodium hydroxide solution into an n‐hexane, dichloromethane (7∶3) solvent system. The mobile phase was made of acetonitrile, 15 mM orthophosphoric acid (37∶63), and 0.25% v/v of triethylamine, with a flow rate of 1 mL/min. Serum samples containing the carvedilol and internal standard, amitriptyline were eluted through a C8, Kromasil KR 100 5C8 column. Retention times of carvedilol and amitriptyline were 6.10 min and 8.44 min, respectively. The intra day and inter day coefficient of variation and percent error values of the assay method were less than 5%. The calibration curve was linear over a concentration range of 5–500 ng/mL. The extraction recovery of carvedilol is more than 75%. The validated method was applied to a pharmacokinetic study of carvedilol in human serum following the administration of a single carvedilol tablet (6.25 mg). Such a method would be ideally suitable for estimation of the drug for pharmacokinetic studies in human volunteers after oral administration of a single or multiple dosage(s) of carvedilol.

Acknowledgment

The authors are grateful to AICTE, New Delhi, India for providing financial assistance.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.